PubMed COVID-19 Clinical Care

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved significantly during the pandemic and resulted in daunting numbers of genomic sequences. Tracking SARS-CoV-2 evolution during persistent cases could provide insight into the

CONCLUSION: Increased entrustment of clinical activity could be implemented in primary and secondary care settings to reproduce the benefits experienced by student vaccinators in front-line roles during the COVID-19 pandemic. Further work might

CONCLUSION: Taken together, our results showed marked differences in the alteration of nonspecific inflammation and damage in the adaptive immune response during the six serial SARS-CoV-2 waves. Considering the inflammatory response of infectious

CONCLUSION: Although the aerobic performance (Max Power/BM) and the metabolic rate (Peak V̇O(2)/BM and Max. lactate) of FS were lower compared to NFS, they were equally able to reach objective exhaustion criteria. The decreased number of FS who

CONCLUSIONS: In patients with COVID-19-infection, DM is a relevant risk factor for adverse events, including mortality. The vulnerable patient group of diabetics with COVID-19 requires intense medical care and monitoring during hospitalization.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M^(pro)) has been targeted for the development of anti-SARS-CoV-2 agents against COVID-19 infection because M^(pro) processes essential viral polyproteins and plays a key

The COVID-19 pandemic led to social restrictions that often prevented us from hugging the ones we love. This absence helped some realize just how important these interactions are to our sense of care and connection. Many turned to digitally mediated

No abstract

Vaccines are widely recognized as the most economically efficient strategy to combat infectious diseases. Community pharmacists, being highly accessible healthcare professionals, have the potential to significantly contribute to the promotion and

This essay explores the problem of trust and truth in states of emergency. Drawing on Giorgio Agamben's theory of biopolitics and his objections to political managerialism I argue that the real problem exposed by the pandemic was not a lack of trust